Molecular Cancer Research · 2019 · 28 citations · 40 references
MedicineMolecular BiologyOncologyEpigeneticsMolecular OncologyTranscriptional RegulationHormonal Cancer TherapyHormonal Gene RegulationNuclear Receptor SignalingNuclear ReceptorsProstate CancerSteroid Hormone SignalingAndrogen Receptor ExpressionAndrogen Receptor RegulationAndrogen ReceptorsCastration-resistant Prostate Cancer TherapyDna-binding MotifsGata FactorsPioneer FactorsReceptor Splice Variants
The androgen receptor (AR) is a key driver of prostate cancer development. Antiandrogens effectively inactivate the AR, but subsequent AR reactivation progresses the disease to castrate-resistant prostate cancer (CRPC). Constitutively active AR splice variants (AR-V) that function unchallenged by current AR-targeted therapies are key drivers of CRPC. Currently, very little is known about the regulation of AR-Vs at the chromatin level. Here, we show that the pioneer factor GATA2 is a critical regulator of AR-Vs. Furthermore, we demonstrate that the GATA2 cistrome in CRPC shares considerable overlap with bromodomain and extraterminal (BET) proteins and is codependent for DNA binding. GATA2 activity is compromised by BET inhibitors, which attenuates the pioneering role of GATA2 in CRPC. In all, this study indicates that GATA2 is a critical regulator of AR-V-mediated transactivation and is sensitive to BET inhibitors, signifying these agents may be efficacious in patients with CRPC which overexpress GATA2. IMPLICATIONS: We have defined novel mechanisms of AR-V and GATA2 regulation in advanced prostate cancer that could be therapeutically exploited.
40
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text
Medicine, Oncology, Pharmacology +14
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor, Nikolaus Schultz, Haley Hieronymus et al. · Cancer Cell · 2010 · 3.8K citations · Full text
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R. Smith, Fred Saad, Simon Chowdhury et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Mathieu Lupien, Jérôme Eeckhoute, Clifford A. Meyer et al. · Cell · 2008 · 1K citations · Full text